furosemide

Del Mar Adopting Enhanced Safety Protocols For Upcoming Summer Meet

Joe Harper, chief executive officer of the Del Mar Thoroughbred Club in Del Mar, Calif., issued a statement on Tuesday concerning new safety protocols being put in place for the 80th summer season of horse racing that begins July 17 at the seaside track. The protocols follow the lead of many of the changes proposed […]

Continue reading
Commentary: The Performance-Enhancing Effects Of Lasix

The Kentucky Derby is just a few days away. In a typical year the focus leading up to the race would be on analyzing contenders, making selections (plural, because of all those exotic wagers), and planning your Derby festivities. There is nothing typical about 2019. The public outrage regarding the 23 equine fatalities during the […]

Continue reading
Kentucky HBPA Opposes Lasix Phase-Out Plan: ‘Inconceivable’ It’s Being Considered

The Kentucky Horsemen’s Benevolent & Protective Association (KHBPA), unalterably opposes the recently-announced plan of several North American tracks, including Keeneland and Churchill Downs, to run 2-year-old races without the anti-bleeder medication Lasix in 2020 and all stakes races in 2021. The KHBPA is the recognized representatives at all five Thoroughbred tracks in the Commonwealth. It […]

Continue reading
Maryland Breeders, Horsemen Issue Position Statement On Lasix

The Maryland Thoroughbred Horsemen’s Association and Maryland Horse Breeders Association issued the following joint statement, signed by MTHA president Timothy L Keefe and MHBA president Michael J. Harrison, DVM. The stakeholders in Maryland’s racing industry are parties to a landmark 10-Year Agreement that has facilitated many positive changes to the way our racing is being […]

Continue reading
Thoroughbred Idea Foundation: Industry Must Come Together On Lasix Issue

The sport which brings us together is at a turning point. We have been divided for far too long on a variety of issues that impact our business. Most notably, the “Lasix debate” has been a debilitating one, inhibiting our collective ability to move ahead. The time has come for the industry to compromise – […]

Continue reading
The Friday Show Presented By The Match Series: On The Lasix Plan

A group of the country’s most well-known racetrack owners unveiled a plan this week to ban the use of the race-day medication, Lasix, first in 2-year-old races and then a year later in all stakes. It sounds simple but it may not be. In this edition of The Friday Show, Scott Jagow and Ray Paulick […]

Continue reading
Industry Reaction To Racetrack Coalition’s Proposed Partial Phase-Out Of Lasix

Reaction was mixed to the announcement on Thursday by a coalition of U.S. racetracks to partially phase out race-day administration of the anti-bleeding diuretic furosemide (Lasix), beginning with 2-year-olds racing in 2020 and in stakes races beginning in 2021. Those supporting the initiative include all tracks owned or operated by Churchill Downs Incorporated (CDI), the […]

Continue reading
Coalition Representing Major U.S. Tracks Announces Lasix Ban For 2-Year-Old Races, Then Stakes

A coalition of leading Thoroughbred racing associations and organizations announced today a new horse racing initiative committed to phasing out the use of the medication Furosemide (Lasix) beginning in 2020 and eliminating the use of Lasix in stakes races held at their racetracks beginning in 2021.  Coalition racetracks that have signed on to this initiative […]

Continue reading
Report: NYRA, Churchill, Keeneland In Talks About Banning Lasix For Juveniles, Stakes Races

According to a report in the Daily Racing Form citing “three officials with knowledge of the discussions, Churchill Downs, the New York Racing Association and Keeneland are considering a two-pronged plan for the elimination of the race-day medication, Lasix. Under the proposal, tracks owned by the three companies would ban Lasix for 2-year-old races in […]

Continue reading
RCI: No Evidence Furosemide Contributes To Breakdowns, No Change In Policy Forthcoming

The Scientific Advisory Group of the Association of Racing Commissioners International (ARCI) has reported that there is no current science linking furosemide treatments to muscular skeletal issues that may be a contributing cause of equine breakdowns in racing. The group reported to a meeting of the RCI’s Drug Testing Standards and Practices Committee that they […]

Continue reading
Twitter Twitter
Paulick Report on Instagram